Solutions

ASSOCIATED PRESS  by Jonathan Paye-Layleh                                                                               Feb. 16, 2015

MONROVIA, Liberia — Students in Liberia began returning to the classroom Monday after a six-month closure during the Ebola epidemic that left thousands dead in this West African country.

In the capital, lines formed outside entrances where returning students' temperatures were being taken. Ebola's main symptom is a high fever, and only those who are sick can spread the deadly virus to others.

Deputy Education Minister Remses Kumbuyah said more than 5,000 kits were distributed to schools that included thermometers and chlorine for hand-washing.

Read complete story.

http://news.yahoo.com/liberia-schools-reopen-6-month-ebola-closure-102403539.html;_ylt=AwrBEiHK9eFUTkwAAOHQtDMD

UNITED NATIONS NEWS CENTRE                                      Feb. 13, 2015
The United Nations World Health Organization (WHO) announced Friday that it will huddle with medical teams from outside the Ebola-affected countries next week in Geneva to see how they can help in the last phases of the fight to bring the number of cases down to zero.
UN Development Program (UNDP) Administrator Helen Clark washes her hands on arrival in Ebola-affected Monrovia, Liberia. Photo: UNDP/Dylan Lowthian

Earlier, UN Development Program (UNDP) Administrator Helen Clark... met with a number community groups in Conakry, Guinea, where she stressed the vital importance of community advocacy in stopping the outbreak. Her mission will conclude with a visit to Sierra Leone early next week.

UNDP is working with the national authorities and local, regional and international partners, including the African Development Bank, the European Union and the World Bank, on an Ebola Recovery Assessment, and in support of national strategies, as part of its mandate to the lead the UN system in the Ebola-related recovery efforts.

submitted by Novil Wijesekara

communityresiliencecenter.org

Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, illness in human with average case fatality rate of around 50% (range 25%-90%). At present, survivors of EVD face psychological effects, social isolation and serious repercussions on health care seeking behavior for EVD.  Ebola Survivor Corps is a comprehensive and sustainable program aimed at getting survivors of EVD back to their communities and society as helpers, advocates, champions and heroes of health and development.

Vision of Ebola Survivor Corps:

A world with zero discrimination for Ebola Survivors

Mission of Ebola Survivor Corps:

To establish a comprehensive and sustainable social organization with Ebola Survivors at the heart for reintegrating, empowering and engaging Ebola Survivors as leaders, advocates, champions and heroes of health and development.

Objectives:

BLOOMBERG  Commentary      by Charles Kenney                                              Feb. 3, 2015
...Without good surveillance, disease threats can fester undetected until they are considerably harder to contain. At the moment, countries simply declare they have the capacity to meet global standards and the WHO takes their word for it. There should be a system of independent review, backed up with international assistance and support to ensure that all countries really do have the capacity to track infectious disease outbreaks and control their spread across borders.

....the global health research system is primarily driven by market pressures. The cost of bringing a drug through the regulatory processes to market averages around $1 billion. That's a big reason why pharmaceutical companies would rather spend money on treatments for the diseases of the rich than for conditions that largely affect people in countries like Liberia...

There are two approaches to deal with that problem: lower the cost of drug development and increase the market for the products that emerge. ...

To increase demand, governments can club together to create an "advanced market commitment": If a drug developer produces a vaccine or therapy that meets certain standards, donors precommit to buy it in bulk....